Skip to main content
SpringerLink
Log in

Adalimumab

Disseminated miliary tuberculosis and immune reconstitution inflammatory syndrome following drug withdrawal: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Christian E, et al. CNS TB-IRIS Following Cessation of Adalimumab in an Adolescent With Crohn's Disease. Open Forum Infectious Diseases 9: No. 8, Aug 2022. Available from: URL: http://doi.org/10.1093/ofid/ofac367

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1935, 20 (2022). https://doi.org/10.1007/s40278-022-28815-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28815-7

Search

Navigation